$15.03
-0.08-0.53%
At close: -
$15.03
0.000.00%
After Hours: 4:34 PM EDT
Comments
Loading...
Takeda Pharmaceutical Co Stock Guidance | NYSE:TAK | Benzinga
Takeda Pharmaceutical Co issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/30/2025 | TAK | Takeda Pharmaceutical Co | FY | 2024 | $3.33 | $3.33 | — | $30.14B | $30.14B | — | Get Alert |
| 10/31/2024 | TAK | Takeda Pharmaceutical Co | FY | 2024 | $3.06 | $3.06 | — | $30.10B | $30.10B | — | Get Alert |
| 07/31/2024 | TAK | Takeda Pharmaceutical | FY | 2024 | $2.77 | $2.77 | — | $27.91B | $27.91B | — | Get Alert |
| 05/09/2024 | TAK | Takeda Pharmaceutical | FY | 2024 | $2.90 | $2.90 | — | $29.32B | $29.32B | — | Get Alert |
| 02/01/2024 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.03 | $3.03 | — | $26.94B | $26.94B | — | Get Alert |
| 10/26/2023 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.09 | $3.09 | — | $27.55B | $27.55B | — | Get Alert |
| 07/27/2023 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.16 | $3.16 | — | $27.99B | $27.99B | — | Get Alert |
| 05/11/2023 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.28 | $3.28 | — | $29.03B | $29.03B | — | Get Alert |
| 02/02/2023 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.72 | $3.72 | — | $27.84B | $27.84B | — | Get Alert |
| 10/27/2022 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.80 | $3.80 | — | $28.46B | $28.46B | — | Get Alert |
| 07/28/2022 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.74 | $3.74 | — | $28.49B | $28.49B | — | Get Alert |
| 05/11/2022 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.99 | $3.99 | — | $30.39B | $30.39B | — | Get Alert |
| 02/03/2022 | TAK | Takeda Pharmaceutical | FY | 2021 | $3.61 | $3.61 | — | $30.48B | $30.48B | — | Get Alert |
| 10/28/2021 | TAK | Takeda Pharmaceutical | FY | 2021 | $3.53 | $3.53 | — | $30.22B | $30.22B | — | Get Alert |
| 07/30/2021 | TAK | Takeda Pharmaceutical | FY | 2021 | $3.59 | $3.59 | — | $30.67B | $30.67B | — | Get Alert |
FAQ
What is the most recent guidance for Takeda Pharmaceutical Co (TAK)?
There have been no specific sales or earnings guidance reported for Takeda Pharmaceutical Co in recent months.
Browse guidance and forecast on all stocks.
